Search Results 401-410 of 16335 for pharmacogenetics
Dr. Halena Gazelka 00:37. Welcome, everyone to Mayo Clinic Q&A. I'm your host, Dr. Halena Gazelka. Mayo Clinic. Biopharma Diagnostics collaborates with ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
The purpose of this study is to establish a safe and tolerated dose of single agent WVT078 in patients with relapsed and/or refractory Multiple Myeloma (MM).
The purpose of this study is to evaluate circulating tumor DNA as a potential biomarker for pre-surgery treatment response in patients who have esophageal ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Zhu, Jane M.D., Ph.D. zhu.shizhen@mayo.edu; Associate Professor of Biochemistry and Molecular Biology; Publications. More about research at Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.